Report Categories
View AllRecent Articles
View All
When GATX Corporation GATX Stock Will Fall Near Lows 20260415
Scinai SCNI Stock Volatility Q4 2023 EPS Exceeds Expectations
Gladstone GOODN Stock Is It a Solid Investment Choice Breakdown Watch 20260418
GEF Greif posts 43 yearoveryear Q3 2025 revenue growth but misses EPS estimates shares dip 074
EBS Emergent BioSolutions reports sharp Q4 2025 EPS miss shares edge down 074 percent on weak results
RRBI Red River beats Q1 earnings estimates by 59 but shares decline 071 on sector concerns
RDGT Ridgetech reports Q3 2011 earnings miss and declining revenue shares fall 265 on weak quarterly performance
Tim Lamb Group Finalizes Sale of Seven Firelands Automotive Group Dealerships in Northern Ohio
Apollo Tyres Strong Quarter Overshadowed by Rising Input Cost Pressures
Trump Suggests He Should Have Sought Larger Intel Stake in Government Deal
Alphabet Boosts 2026 Capex to 190 Billion Signals Further Expansion in 2027
Innovative Eyewear LUCY Q4 2025 Earnings Surprise EPS 014 Up Significant
McCormick MKC Q1 2026 Earnings Beat Revenue NA EPS 066
Perpetua Resources Secures 29 Billion US ExportImport Bank Loan for Idaho Critical Minerals Project
China Investors Shift Funds After Crackdown on Overseas Stock Trading
Bond Market Signals Concern That Fed Is Behind the Curve on Inflation as Warsh Takes Helm
A Funds 28 Million Exit From a SaaS Stock After a 15 Decline What It Signals
US Stock Futures Decline as Uncertainty Clouds USIran Diplomatic Talks
Morgan Stanley Raises Aflac Price Target to 125 Citing Favorable Insurance Trends
ATI Q1 2026 Earnings Strong EPS Surprise of 124 Outpaces Analyst Expectations Stock Edges Lower
CNTB Q1 2026 Earnings Significant EPS Miss as Biotech Continues PreRevenue Phase
Atour Lifestyle Holdings Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Uptick
PBA Q1 2026 Earnings Earnings Beat Estimates on Strong Operational Execution
LOVE Q1 2026 Earnings EPS Beats Estimates by 682
Washington Trust Bancorp Inc WASH Q1 2026 Earnings EPS Misses Estimates as Net Interest Margin Faces Pressure
Calamos Strategic Total Return CSQ Holds Steady Near Resistance as Price Action Remains Cautious
LENZ Therapeutics LENZ Edges Lower as Stock Tests Support at 730
Aurora Cannabis ACB Gains 153 Testing Resistance at 369
Cyclerion Therapeutics CYCN Edges Higher as Shares Test Key Resistance Levels
Kinross Gold KGC Steps Back from Resistance Support Levels in Focus